Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cheers to the smart long-term holders at ImmuPharma! You guys saw the value when others doubted, sticking with it through thick and thin. Here's to more wins and proving the skeptics wrong. Keep believing, the best is yet to come! GoldGirl, welcome to the board, love the positive attitude! Long term holders will get the Ferrari, and short-term the roll-skaters or nothing at all.
Flash: Really, next time you pop out from that gloomy, stinky, and sad hole of yours, try pulling out a brain instead of those outdated misleading comments and pessimistic views, will ya? It's a spectacle, seeing you miss out while ImmuPharma's share price more than doubled. A round of applause for Flash, folks, the magician who could've made folks miss a golden run if they'd listened to him. Thankfully, wisdom prevailed, and nobody's fallen for his stupid act. READ! "Future cash requirements are fully expected to be met through non-dilutive income derived from the Company's portfolio of assets including, inter alia, new commercial deals on the development portfolio, including the non-US rights for P140 (SLE/Lupus); the worldwide rights for CIDP and for BioAMB. The Company is in active discussions with a broad range of potential commercial partners with the objective of completing deals across the portfolio in 2024." Read it again and again! You are a pathetic loser!
Moneymule888: What's your deal? Advising a short when ImmuPharma's only shown resilience and growth. If anyone had taken that advice seriously, they'd be biting nails watching the price soar more than 100% since you made your stupid comments, missing out on a stellar climb. Good thing the crowd's got more sense than to follow such gloomy nonsense prophecies. You are a loser and a pathetic soul too! Negativity and stupidity are the perfect recipe for catastrophic investments and life in general.
ImmuPharma's not just bouncing back; it's leaping forward, proving all the naysayers wrong. With every upward tick, it shows the company's underlying value and potential. So, to the bearish brigade, might be time to pack up the doom and gloom - this show's over, and the future's looking bright for ImmuPharma and its believers :)
I think Immu has huge potential.Post Trial 3 failure team has done so much and with skilled and experienced team behind and multi dollor Avion backing and Lupus in final phase ( Billion dollar Market).Current share price is Bargain..Easy 10 baggers from here.No dilution as previous RNS clearly states if you can read and understand.
Future cash requirements are fully expected to be met through non-dilutive income derived from the Company's portfolio of assets including, inter alia, new commercial deals on the development portfolio, including the non-US rights for P140 (SLE/Lupus); the worldwide rights for CIDP and for BioAMB. The Company is in active discussions with a broad range of potential commercial partners with the objective of completing deals across the portfolio in 2024.
I'm with you, Oldbutno. Something may or may not be going on but P & D crew out in force today!
Bought a few more even though these are making me losses at present SP. Didn't cost a lot and with them getting a bit of interest, they might have now hit bottom (although my hunch is another 'pump 'n' dump)
Even candidate drugs in preclinical stage are worth millions, and we have the advantage of rare diseases and are not a one trick pony.
I remember imm when it was worth few quid per share. Anyone taking a stake now are buying in at the bottom
Gla
No dilution
CEO had that in his rns
Stop trying to scare folk
A substantial deal means 20p plus
No arguments
We have the assets
Gla
" Yeah because a deal gets done overnight at a conference lol "
you "sign" deals at a conference .....after MONTHS of getting a deal done !!!
and SP movement looks like there is some leak on that !!!! (maybe)
Don't be surprised if we close well over 3p today
Gla
Share price on 1st March 2024
0.85:
Advice from the Moneymule "In freefall". "Short".
Actually it stabilised at that price and is now up 125% after his his advice to short. LOL.
Did anyone follow his advice?
The Great Wisdom of Moneymule888
"You might as well short IMM or sell and buy back cheaper in a month following the RI"
If the man followed his own advice he must be down significantly. Unless he does not trade and just likes giving out unasked for advice.
What a clown.
2.20p paid
This is going to break out imvho
Gla
Will get noticed
2nd on risers model
Dallo
See my earlier note-there is no decency in the day trading business-so we must focus on the medium term-the fundamentals are the key. There will be good news-the price will adjust-some time along the road proper investment decisions will have to be made. Pleased I have averaged down hugely.
Non-dilutive
Rare disease area
Big audience conference next week
Share will go up on rumour of deals
Gla
I'm in
Gla
Flash says sell as the rise is capped at 2p.
Is that a 2.2p trade I have just seen going through.
At least Lambo had the decency to move on.
Dallo,
As Saïd a few weeks Back, one could expect some deal to be signed in the near future and Biotech europe might be the right venue for such an annoncement...
Only Time will tell .
Dallo,
I just did the opposite and sold into the rise,
Now my speculation in Immupharma is 100% risk free.
my number one priority is not to loose my original stake.
At weekly 50 ema sm resistance ,overall bullish bias since it crossed 21ema ,im going to be bold and say if it stay abve the 50ema we may see 5's which is c 200ema
https://invst.ly/13-qv7
Dallo - "I wonder is there anything substantive driving this rally"
Probs individuals realising it's not going to get cheaper ...lol
GL SR
Bought again today
Now about to go through 2p and £2m warrants exercise price.
A long way from liquidation and a further death spiral funding from Lanstead.
I wonder is there anything substantive driving this rally.
A lot of buying going on.
This is just a matter of being patient and holding till we push it over the line.
Where is Nobinpus when you want him ; )
Have a good weekend all and enjoy the rise.
Fritz
Of course they have gone silent. Pushed the price down-loaded up-RNS positive-as expected-price doubles-sell.
Worked in top broking house years ago-switched on sales partner gets an idea-buys-tell other partners -they buy-all tell their clients-they buy-original partner sells.
Ignore the aptly named flash and his pals-it's the same old-same old.
GLA
Igno